Tus kws kho mob
QP48-25 Commercial Pharmacy Benefit Exclusion for Imaavy™, Ustekinumab and Ustekinumab-aekn
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
This policy addresses coding and reimbursement for Cellular and Gene Therapy Products. This policy does not apply to FEP.
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2024